ATIN: Sharp drop in sales and earnings; Ivisys spin-off and strong Zalaris, Pace growth

About this update from Athanase Innovation Ab

Net sales and value changes from securities declined sharply year-over-year, leading to a negative operating result. The board is preparing to distribute Ivisys shares to shareholders, while investments in Zalaris and Pace showed strong growth. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Athanase Innovation Ab